Do you want to read an article? Please log in or register.
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis
Rheumatoid Arthritis
Related content
Further Publications Rheumatology
EULAR recommendations for a core data set for pregnancy registries in rheumatology
Ann Rheum Dis
Meissner Y, Fischer-Betz R, Andreoli L, Costedoat-Chalumeau N, De Cock D, Dolhain RJEM, Forger F, Goll D, Molto A, Nelson-Piercy C, Özdemir R, Raio L, Rodríguez-García SC, Sciascia S, Wallenius M, Zbinden A, Zink A, Strangfeld A
doi: 10.1136/annrheumdis-2020-218356
Rheumatoid Arthritis
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
Ann Rheum Dis.
Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JWJ, Burmester GR, de Wit M, Falzon L, Landewé R
doi: 10.1136/annrheumdis-2019-216656.
Further Publications Rheumatology
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
Ann Rheum Dis
Mankia K, Siddle HJ, Kerschbaumer A, Alpizar Rodriguez D, Catrina AI, Canete JD, Cope AP, Daien CI, Deane KD, El Gabalawy H, Finckh A, Holers VM, Koloumas M, Ometto F, Raza K, Zabalan C, van der Helm-van Mil A, van Schaardenburg D, Aletaha D, Emery P
doi: 10.1136/annrheumdis-2021-220884
Rheumatoid Arthritis
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries
Ann Rheum Dis.
Meisters R, Putrik P, Ramiro S, Hifinger M, Keszei AP, van Eijk-Hustings Y, Woolf AD, Smolen JS, Stamm TA, Stoffer-Marx M, Uhlig T, Moe RH, de Wit M, Tafaj A, Mukuchyan V, Studenic P, Verschueren P, Shumnalieva R, Charalambous P, Vencovský J, Varvouni M, Kull M, Puolakka K, Gossec L, Gobejishvili N, Detert J, Sidiropoulos P, Péntek M, Kane D, Scirè CA, Arad U, Andersone D, van de Laar M, van der Helm-van Mil A, Głuszko P, Cunha-Miranda L, Berghea F, Damjanov NS, Tomšič M, Carmona L, Turesson C, Ciurea A, Shukurova S, Inanc N, Verstappen SM, Boonen A, Working group
doi: 10.1136/annrheumdis-2020-217520.
Rheumatoid Arthritis
Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
Rheumatol Ther.
Pappas DA, Kremer JM, Griffith J, Reed G, Salim B, Karki C, Garg V
doi: 10.1007/s40744-017-0077-z.
Further Publications Rheumatology
Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative
Semin Arthritis Rheum
Bruera S, Carmona L, Lopez-Olivo MA, Westrich-Robertson T, March L, Negron JB, Christensen R, Strand V, Ingegnoli F, Goel N, Shea B, Tugwell P, Leong A, Bingham CO, Hill CL, Suarez-Almazor ME
doi: 10.1016/j.semarthrit.2021.08.003
Psoriatic Arthritis
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis
Arthritis Rheumatol.
Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ, Helliwell PS
doi: 10.1002/art.40391.
RECOMMENDED
Rheumatoid Arthritis
2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures
★ 1
Recommended by
Dr Heino Prillwitz, Faculty Member
Arthritis Care Res (Hoboken).
England BR, Tiong BK, Bergman MJ, Curtis JR, Kazi S, Mikuls TR, O'Dell JR, Ranganath VK, Limanni A, Suter LG, Michaud K
doi: 10.1002/acr.24042.
Rheumatoid Arthritis
Comparative effectiveness of certolizumab pegol, abatacept and biosimilar infliximab in patients with rheumatoid arthritis treated in routine care. Observational data from the Danish DANBIO registry emulating a randomized trial
Arthritis Rheumatol.
Grøn KL, Glintborg B, Nørgaard M, Mehnert F, Østergaard M, Dreyer L, Krogh NS, Bjorner JB, Hetland ML
doi: 10.1002/art.41031.